Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1995; Volume 275,Issue 2
  • You have access
    Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
    M Lee, K H Yang and N E Kaminski
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 529-536;
  • You have access
    Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice.
    A Takagi, H Masuda, Y Takakura and M Hashida
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 537-543;
  • You have access
    Sensitization to the behavioral effect of kainic acid in the mouse is mediated by nitric oxide.
    A A Larson and K F Kitto
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 544-550;
  • You have access
    Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice.
    H S Kim and W K Park
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 551-557;
  • You have access
    Supra-additive natriuretic synergism between bendroflumethiazide and furosemide in rats.
    T E Jonassen, L Grønbeck, M Shalmi, J S Petersen, F Andreasen and S Christensen
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 558-565;
  • You have access
    Variability in human cytochrome P450 paclitaxel metabolism.
    D S Sonnichsen, Q Liu, E G Schuetz, J D Schuetz, A Pappo and M V Relling
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 566-575;
  • You have access
    Serotonin stimulates rapid increase of inositol 1,4,5-trisphosphate in ovine uterine artery: correlation with contractile state.
    L Zhang and X Q Hu
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 576-583;
  • You have access
    HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro.
    G Abou-Mohamed, A Papapetropoulos, D Ulrich, J D Catravas, R R Tuttle and R W Caldwell
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 584-591;
  • You have access
    N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors.
    J Schmider, D J Greenblatt, L L von Moltke, J S Harmatz and R I Shader
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 592-597;
  • You have access
    Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.
    C E Tedford, S L Yates, G P Pawlowski, J W Nalwalk, L B Hough, M A Khan, J G Phillips, G J Durant and R C Frederickson
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 598-604;
  • You have access
    Factors affecting serum protein binding of cocaine in humans.
    R B Parker, C L Williams, S C Laizure and J J Lima
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 605-610;
  • You have access
    Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
    P K Rangachari, P A Betti, E T Prior and L J Roberts
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 611-617;
  • You have access
    Antinociceptive effects of R(-)- and S(+)-flurbiprofen on rat spinal dorsal horn neurons rendered hyperexcitable by an acute knee joint inflammation.
    V Neugebauer, G Geisslinger, P Rümenapp, F Weiretter, I Szelenyi, K Brune and H G Schaible
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 618-628;
  • You have access
    Effects of intrathecal and intracerebroventricular buprenorphine on a C-fiber reflex in the rat.
    F Guirimand, M Chauvin, J C Willer and D Le Bars
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 629-637;
  • You have access
    Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
    M M Usowicz, M Gigg, L M Jones, C W Cheung and S A Hartley
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 638-645;
  • You have access
    Cardiovascular responses to cigarette smoke exposure in restrained conscious rats.
    A A Houdi, R T Dowell and J N Diana
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 646-653;
  • You have access
    Depletion of hepatic 3'-phosphoadenosine 5'-phosphosulfate (PAPS) and sulfate in rats by xenobiotics that are sulfated.
    H J Kim, J H Cho and C D Klaassen
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 654-658;
  • You have access
    Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
    L Simon, B Ghaleh, L Puybasset, J F Giudicelli and A Berdeaux
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 659-666;
  • You have access
    Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
    S Cardin, A H Soll and Y Taché
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 667-673;
  • You have access
    Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway.
    H Chen, H Li and D M Chuang
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 674-680;
  • You have access
    Pinacidil relaxes porcine and human coronary arteries by activating ATP-dependent potassium channels in smooth muscle cells.
    M Gollasch, R Bychkov, C Ried, F Behrendt, S Scholze, F C Luft and H Haller
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 681-692;
  • You have access
    Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    C Rundfeldt, P Wlaź, D Hönack and W Löscher
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 693-702;
  • You have access
    Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    R E Howell, L P Jenkins and D E Howell
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 703-709;
  • You have access
    Prostaglandin E2 contracts vascular smooth muscle and inhibits potassium currents in vascular smooth muscle cells of rat tail artery.
    J Ren, E Karpinski and C G Benishin
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 710-719;
  • You have access
    Galanin receptors in human basal forebrain differ from receptors in the hypothalamus: characterization using [125I]galanin (porcine) and [125I]galantide.
    D C Deecher, O O Odusan and E J Mufson
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 720-727;
  • You have access
    Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.
    M Suzuki, T Yamaguchi, Y Ozawa, M Ohyama and M Yamamoto
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 728-736;
  • You have access
    Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
    B D Gitter, R F Bruns, J J Howbert, D C Waters, P G Threlkeld, L M Cox, J A Nixon, K L Lobb, N R Mason and P W Stengel
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 737-744;
  • You have access
    Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    N C Trippodo, J A Robl, M M Asaad, J E Bird, B C Panchal, T R Schaeffer, M Fox, M R Giancarli and H S Cheung
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 745-752;
  • You have access
    NMDA antagonist properties of the putative antiaddictive drug, ibogaine.
    P Popik, R T Layer, L H Fossom, M Benveniste, B Geter-Douglass, J M Witkin and P Skolnick
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 753-760;
  • You have access
    U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes.
    A H Tang, M W Smith, D B Carter, W B Im and P F VonVoigtlander
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 761-767;
  • You have access
    Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice.
    J Liu, Y Liu, A Parkinson and C D Klaassen
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 768-774;
  • You have access
    Increased function of voltage-dependent Ca++ channels and Ca(++)-activated K+ channels in resting state of femoral arteries from spontaneously hypertensive rats at prehypertensive stage.
    M Asano, Y Nomura, K Ito, Y Uyama, Y Imaizumi and M Watanabe
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 775-783;
  • You have access
    Chronic neurosteroid treatment decreases the efficacy of benzodiazepine ligands and neurosteroids at the gamma-aminobutyric acidA receptor complex in mammalian cortical neurons.
    R Yu and M K Ticku
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 784-789;
  • You have access
    Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization.
    A J Roberts, C N Lessov and T J Phillips
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 790-797;
  • You have access
    EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine.
    P K Gonzalez, J Zhuang, S R Doctrow, B Malfroy, P F Benson, M J Menconi and M P Fink
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 798-806;
  • You have access
    KR-30450, a newly synthesized benzopyran derivative, activates the cardiac ATP-sensitive K+ channel.
    Y G Kwak, S K Park, H S Kang, J S Kim, S W Chae, K P Cho, S E Yoo and D Kim
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 807-812;
  • You have access
    Effects of photodegradation products of nifedipine: the nitroso-derivative relaxes contractions of the rat aortic strip induced by norepinephrine and other agonists.
    N Hayase, S Inagaki and Y Abiko
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 813-821;
  • You have access
    A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    R Schreiber, M Brocco, B Lefèbvre de Ladonchamps, S Monneyron and M J Millan
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 822-831;
  • You have access
    Plasma digoxin immunoreactivity and arterial potassium relaxation after quinapril therapy in hypertensive rats.
    M Kähönen, P A Doris, H Mäkynen and I Pörsti
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 832-837;
  • You have access
    Muscarine induces an anomalous inhibition of synaptic transmission in rat auditory thalamic neurons in vitro.
    D M Mooney, B Hu and V V Senatorov
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 838-844;
  • You have access
    (+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland.
    L Steardo, P Monteleone, M d'Istria, I Serino, M Maj and V Cuomo
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 845-849;
  • You have access
    Effects of methylprednisolone and 21-aminosteroids on mitogen-induced interleukin-6 and tumor necrosis factor-alpha production in human peripheral blood mononuclear cells.
    F Buttgereit, I Brink, B Thiele, G R Burmester, F Hiepe and E D Hall
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 850-853;
  • You have access
    Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    O Edling, G Bao, M Feelisch, T Unger and P Gohlke
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 854-863;
  • You have access
    Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
    R Bouchard and D Fedida
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 864-876;
  • You have access
    Regulation of striatal cyclic-3',5'-adenosine monophosphate accumulation and GABA release by glutamate metabotropic and dopamine D1 receptors.
    J Wang and K M Johnson
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 877-884;
  • You have access
    Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
    M J Millan, J L Peglion, J Vian, J M Rivet, M Brocco, A Gobert, A Newman-Tancredi, C Dacquet, K Bervoets and S Girardon
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 885-898;
  • You have access
    Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    A Gobert, J M Rivet, V Audinot, L Cistarelli, M Spedding, J Vian, J L Peglion and M J Millan
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 899-913;
  • You have access
    Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.
    C Casati, A Monopoli, A Forlani, E Bonizzoni and E Ongini
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 914-919;
  • You have access
    Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig.
    K Ito, K Ito, Y Sawada, J Kamei, M Misawa and T Iga
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 920-925;
  • You have access
    Peritubular paraquat transport in isolated renal proximal tubules.
    C E Groves, M N Morales, A J Gandolfi, W H Dantzler and S H Wright
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 926-932;
  • You have access
    Membrane permeability and lipophilicity in the isolated perfused rat liver: 5-ethyl barbituric acid and other compounds.
    C Chou, A J McLachlan and M Rowland
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 933-940;
  • You have access
    Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis.
    C F Toombs, G L DeGraaf, J P Martin, J G Geng, D C Anderson and R J Shebuski
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 941-949;
  • You have access
    Mechanisms of ethanol-induced suppression of a primary antibody response in a mouse model for binge drinking.
    Y C Han and S B Pruett
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 950-957;
  • You have access
    Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
    T Lindmark, T Nikkilä and P Artursson
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 958-964;
  • You have access
    Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein.
    R A Dean, J Zhang, M R Brzezinski and W F Bosron
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 965-971;
  • You have access
    Age- and sex-related alterations of microsomal drug- and testosterone-oxidizing cytochrome P450 in Sprague-Dawley strain-derived dwarf rats.
    M Shimada, N Murayama, Y Yamazoe, H Hashimoto, H Ishikawa and R Kato
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 972-977;
  • You have access
    Characterization of alpha 2 adrenoceptors and other adrenoceptors in membranes isolated from dog mesenteric nerve axons.
    E E Daniel, V Gaspar, I Berezin and C Y Kwan
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 978-986;
  • You have access
    Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
    M Bencherif, K Fowler, R J Lukas and P M Lippiello
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 987-994;
  • You have access
    Anti-inflammatory properties of Gö 6850: a selective inhibitor of protein kinase C.
    P B Jacobson, S L Kuchera, A Metz, C Schächtele, K Imre and D J Schrier
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 995-1002;
  • You have access
    Anti-dopamine beta-hydroxylase immunotoxin-induced sympathectomy in adult rats.
    M J Picklo, R G Wiley, S Lonce, D A Lappi and D Robertson
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1003-1010;
  • You have access
    Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
    E G Schuetz, K N Furuya and J D Schuetz
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1011-1018;
  • You have access
    Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    R C Pierce and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1019-1029;
  • You have access
    [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
    D C Perry and K J Kellar
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1030-1034;
  • You have access
    Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction.
    M A Scofield, F Liu, P W Abel and W B Jeffries
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1035-1042;
  • You have access
    The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
    H M Cherwinski, R G Cohn, P Cheung, D J Webster, Y Z Xu, J P Caulfield, J M Young, G Nakano and J T Ransom
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1043-1049;
  • You have access
    Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    R L Smith, R J Barrett and E Sanders-Bush
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1050-1057;
  • You have access
    Cyclopiazonic acid, inhibiting the endoplasmic reticulum calcium pump, reduces the canine colonic pacemaker frequency.
    L W Liu, L Thuneberg and J D Huizinga
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1058-1068;
  • You have access
    Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine.
    M Visentin, R Bellasio and M T Tacconi
    Journal of Pharmacology and Experimental Therapeutics November 1995, 275 (2) 1069-1075;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 275, Issue 2
1 Nov 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics